Atrial fibrillation (AF) is a common heart arrhythmia in the general population with prevalence increasing with age, affecting nearly 6% of individuals over 65 years. There are many cardiac conditions that may predispose to the development of this arrhythmia, although it was observed in the recent years that genetics may be the cause in 5%-15% of cases diagnosed with isolated AF.
Patients with a family history of atrial fibrillation in the absence of predisposing factors such as hypertension, ischemic cardiomyopathy, or structural heart diseases.
The probability of finding a pathogenic
mutation when a patient presents
atrial fibrillation has not been clearly
established. The yield could be higher
in cases where there is a family history
of this disorder and when it occurs in
young subjects without a clear cause.
How to order
1. Download & fill out
Please cover as many fields as possible in both documents
2. Sample collection
Three sample types: saliva, peripheral blood or genomic DNA
3. Pack the sample
Please pack the sample in a way to prevent leakage
4. Send the sample & the request
Please schedule the delivery for Mon–Thur: 8am – 5pm
5. Result: the report
Via: Client Site HIC / Client Site Imegen / Certified email
Turnaround time (TAT): 4 weeks
Ref. S-201906450
Priority Genes : Genes where there is sufficient evidence (clinical and functional) to consider them associated with the disease; they are included in the clinical practice guidelines.
Secondary Genes: Genes related to the disease, but with a lower level of evidence or that constitute sporadic cases.
* Candidate Genes: Not enough evidence in humans, but potentially associated with the disease.
Panel that include atrial fibrillation genes
Panel that include atrial fibrillation genes
Panel that include atrial fibrillation genes
